reference/19699155

http://rdf.ncbi.nlm.nih.gov/pubchem/reference/19699155

Outgoing Links

Predicate	Object
contentType	Journal Article\|Research Support, Non-U.S. Gov't
endingPage	1194
issn	1559-2294 1559-2308
issueIdentifier	10
pageRange	1180-1194
publicationName	Epigenetics
startingPage	1180
hasFundingAgency	http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_487baf6554eb36bb22c6138d90a7c50f http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_1020ae2648a6e404cf3405e5b1ee7d63
bibliographicCitation	Lyu R, Zhu X, Shen Y, Xiong L, Liu L, Liu H, Wu F, Argueta C, Tan L. Tumour suppressor TET2 safeguards enhancers from aberrant DNA methylation and epigenetic reprogramming in ERα-positive breast cancer cells. Epigenetics. 2021 Oct 30;17(10):1180–94. doi: 10.1080/15592294.2021.1997405.
creator	http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_f211ecc0484a3855b776251fd5a483d1 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_ccc84e9b4fd7e112858bc0b7dac72bda http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_2552a235ae50fba46df94e4fbdd014bc http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_08124375decbe05af964e6100a9f4a9a http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_47aec106cf5a2f1b4754a9f5338c2444 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_cb713d3e97c64876e717c592fef9dd21 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_3b638a3e2f726437b530180e302c9d47 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_0b75beb42252367977e6930f3467844b http://rdf.ncbi.nlm.nih.gov/pubchem/author/ORCID_0000-0003-4597-1604 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_c09313f37761aa2f52195959405a9f29
date	2021-10-30-04:00^^<http://www.w3.org/2001/XMLSchema#date>
identifier	https://pubmed.ncbi.nlm.nih.gov/34689714 https://doi.org/10.1080/15592294.2021.1997405 https://pubmed.ncbi.nlm.nih.gov/PMC9542862
isPartOf	https://portal.issn.org/resource/ISSN/1559-2294 http://rdf.ncbi.nlm.nih.gov/pubchem/journal/33241 https://portal.issn.org/resource/ISSN/1559-2308
language	English
source	https://www.crossref.org/ https://pubmed.ncbi.nlm.nih.gov/
title	Tumour suppressor TET2 safeguards enhancers from aberrant DNA methylation and epigenetic reprogramming in ERα-positive breast cancer cells
discusses	http://id.nlm.nih.gov/mesh/M0464092 http://id.nlm.nih.gov/mesh/M0280632 http://id.nlm.nih.gov/mesh/M0007772 http://id.nlm.nih.gov/mesh/M0006678 http://id.nlm.nih.gov/mesh/M0006644 http://id.nlm.nih.gov/mesh/M0007795 http://id.nlm.nih.gov/mesh/M0019167 http://id.nlm.nih.gov/mesh/M0017909 http://id.nlm.nih.gov/mesh/M0013670 http://id.nlm.nih.gov/mesh/M0022149 http://id.nlm.nih.gov/mesh/M0536248
hasPrimarySubjectTerm	http://id.nlm.nih.gov/mesh/D001943Q000235 http://id.nlm.nih.gov/mesh/D049308Q000378 http://id.nlm.nih.gov/mesh/D001943Q000473
hasSubjectTerm	http://id.nlm.nih.gov/mesh/D019175 http://id.nlm.nih.gov/mesh/D012333Q000378 http://id.nlm.nih.gov/mesh/D011518Q000378 http://id.nlm.nih.gov/mesh/D004967 http://id.nlm.nih.gov/mesh/D004958 http://id.nlm.nih.gov/mesh/D004268Q000378 http://id.nlm.nih.gov/mesh/D004268Q000235 http://id.nlm.nih.gov/mesh/D014408Q000378 http://id.nlm.nih.gov/mesh/D047628Q000378 http://id.nlm.nih.gov/mesh/D047628Q000235 http://id.nlm.nih.gov/mesh/D044127 http://id.nlm.nih.gov/mesh/D011518Q000235 http://id.nlm.nih.gov/mesh/D004247Q000378 http://id.nlm.nih.gov/mesh/D004742 http://id.nlm.nih.gov/mesh/D006801 http://id.nlm.nih.gov/mesh/D005260 http://id.nlm.nih.gov/mesh/D008780Q000235
discussesAsDerivedByTextMining	http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_9e97a47eb9e6c78b61149c74e7330d8f http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8607 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID9476 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID7102 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID11431 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5757

Incoming Links

Predicate	Subject
isDiscussedBy	http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID54790

Total number of triples: 70.